Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance

Neurocrine Bio. (NBIX) PT Raised to $158 at Citi

August 1, 2024 3:55 PM EDT

Citi analyst David Hoang raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $158.00 (from $150.00) while maintaining a Neutral rating.

The analyst comments "NBIX reported 2Q24 results and corporate updates. Ingrezza surprised with a healthy beat ~$40M above consensus and ~$50M above our... More